The four peptide families: a practical classification for patients

Peptide families explained — a field map of the peptide world, sorted by what they do, not by what their molecules look like.

TL;DR

• Most patient questions fit into four families: growth, healing, metabolic, and signaling.
• The split is by function, not by chemistry, which is what curious readers usually care about.
• Knowing the family helps you ask better questions about access, evidence, and trade-offs.

What it is

A peptide (in plain English: a short chain of amino acids that acts like a small biological message) can be sorted in many ways. Chemists sort them by structure. Patients sort them by job. The four-family map below is the working version most clinicians use when a curious patient asks “what kind of peptide is this?” Think of it like the kitchen drawer where you keep tools — knives in one slot, openers in another, spoons in a third. Same drawer, different jobs.

How it works

Each family signals a different system. Growth peptides (sermorelin, CJC-1295, ipamorelin) nudge the pituitary gland — the body’s hormone thermostat — to release more of its own growth hormone. Healing peptides (BPC-157, TB-500, GHK-Cu) are studied for tissue repair and inflammation control. Metabolic peptides (GLP-1 medicines like semaglutide and tirzepatide) mimic the body’s fullness and insulin signals. Signaling peptides (PT-141, oxytocin, selank) carry messages to brain receptors involved in desire, bonding, and stress.

Who asks about it

People come to this topic when they keep hearing peptide names and want a single mental shelf to put them on. Patients comparing options for sleep, recovery, weight, or libido often land here first.

What the research says

Each family has a different evidence base. Metabolic peptides have the deepest human evidence (large trials like STEP and SURMOUNT for GLP-1 medicines). Growth peptides have decades of endocrine literature for short stature use. Healing peptides have abundant animal studies and limited human trials. Signaling peptides like PT-141 have FDA-approved indications for specific conditions, while others remain investigational. Lumping them together hides this gap. Asking “which family?” makes the question of evidence much sharper.

What to know before considering it

Peptides require a licensed clinician. Each family has its own side-effect profile and monitoring needs. Compounded peptides are not FDA-approved. The family map is a teaching tool, not a shopping list.

The Halftime POV

We remove the mystery by giving readers a clear shelf to put new names on. When a podcast guest mentions a peptide you have not heard of, you should be able to ask one question: which family? That question alone filters most of the noise out of this space.

Related reading:

• What are peptides? A plain-English primer
• How peptides differ from hormones
• How peptides bind to receptors

FAQ

Q: How many types of peptides are there? A: Researchers describe many subgroups, but most patient questions fit into four practical families: growth, healing, metabolic, and signaling.

Q: What family is BPC-157 in? A: BPC-157 is studied as a healing peptide. The published literature focuses on tissue repair and gut lining models, mostly in animals.

Q: Is GLP-1 a peptide? A: Yes. Semaglutide and tirzepatide are peptide-based metabolic medicines that mimic the body’s own fullness signal.

Disclaimer

This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.

Get updates

Halftime Health is launching soon. Join the waitlist for updates.

Sources

• National Center for Biotechnology Information. Peptide therapeutics overview. https://www.ncbi.nlm.nih.gov/books/NBK542203/
• Wilson JL, et al. Therapeutic peptides — current and emerging applications. PubMed. https://pubmed.ncbi.nlm.nih.gov/
• US Food and Drug Administration. Pharmacy compounding overview. https://www.fda.gov/drugs/human-drug-compounding

This article discusses compounds that are currently under FDA Category 2 review (see our FDA categorization explainer). These compounds are not currently part of Halftime Health’s published protocol catalog. This article is provided for educational purposes only and does not constitute medical advice or an offer to sell.